Related Experiment Video
Updated: May 8, 2026
13:35
Segmentation and Linear Measurement for Body Composition Analysis using Slice-O-Matic and Horos
Published on: March 21, 2021
[Changes in body composition of oncological patients receiving nutritional support]
Summary
Gastric cancer patients experience malnutrition, but nutritional support significantly improves their nutritional status. This study highlights the importance of early intervention for better outcomes in cancer patients.
Area of Science:
- Oncology
- Clinical Nutrition
Background:
- Gastric cancer and its treatment, such as gastrectomy, often lead to malnutrition.
- Undernutrition is a common complication in cancer patients, regardless of disease stage.
Purpose of the Study:
- To investigate body mass loss and body composition changes in gastric cancer patients post-surgery.
- To evaluate the effectiveness of nutritional support in improving the nutritional status of these patients.
Main Methods:
- An open prospective cohort case-control study involving 64 gastric cancer patients (stages II-IV) undergoing surgery.
- 34 patients received additional enteral nutrition for 8 weeks; outcomes were assessed over 12 months.
- Nutritional status was evaluated by monitoring body mass, body composition, total protein, albumin, hemoglobin, and lymphocyte counts.
Main Results:
- Gastric cancer progression is associated with worsening malnutrition.
- Nutritional support demonstrated a significant positive impact on the nutritional status of oncological patients.
- Key indicators like body mass and body composition showed improvement with nutritional intervention.
Conclusions:
- Undernutrition is a progressive issue in gastric cancer patients.
- Additional enteral nutrition is an effective strategy to enhance the nutritional status of cancer patients.
- Timely nutritional support is crucial for managing malnutrition in patients with gastric cancer.
Related Concept Videos
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:28Chronic Kidney Disease III: Interprofessional Care
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...